VanEck Genomics and Healthcare Innovators UCITS ETF
CURE.DE
#3265
ETF rank
ยฃ10.17 M
Marketcap
๐Ÿ‡ช๐Ÿ‡บ EU
Market
ยฃ16.68
Share price
0.52%
Change (1 day)
8.94%
Change (1 year)

Expense ratio and fees for VanEck Genomics and Healthcare Innovators UCITS ETF (CURE.DE)

Total Expense Ratio

Total Expense Ratio as of July 2026: 0.35%